TP53 and sarcoma: Ad-p53 22/23, an adenovirus vector encoding a transcription-defective p53 mutant, is able to induce limited apoptosis compared to Ad-wt p53 in both sarcoma cell lines tested, even combined with doxorubicin or cisplatin.